Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · IEX Real-Time Price · USD
14.83
-0.70 (-4.51%)
At close: Jul 19, 2024, 4:00 PM
14.93
+0.10 (0.67%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $191.01 million as of July 22, 2024. Its market cap has increased by 66.10% in one year.
Market Cap
191.01M
Enterprise Value
185.50M
1-Year Change
66.10%
Ranking
Category
Stock Price
$14.83
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $191.01M, an increase of 178.08%. That is a compound annual growth rate of 30.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 191.00M | 41.27% |
| Dec 29, 2023 | 135.20M | -30.77% |
| Dec 30, 2022 | 195.30M | -38.83% |
| Dec 31, 2021 | 319.30M | -27.15% |
| Dec 31, 2020 | 438.30M | 538.10% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renovaro Biosciences | 199.13M |
| P3 Health Partners | 197.60M |
| Trevi Therapeutics | 195.81M |
| ClearPoint Neuro | 193.86M |
| Generation Bio Co. | 191.60M |
| G1 Therapeutics | 189.78M |
| EDAP TMS | 189.23M |
| Lineage Cell Therapeutics | 188.82M |